OTA elimination backed by Senate Appropriations Chair Mack; hearing questions whether office is essential.
Executive Summary
OTA WORK CAN BE REPLICATED BY OTHER SOURCES, which increases the likelihood of the Office of Technology Assessment's elimination, Senate Appropriations/Legislative Branch Subcommittee Chairman Mack (R-Fla.) contended at a May 26 hearing. Mack noted that the key question in deciding whether to eliminate OTA is whether the information it provides can be supplied by other sources, and he asserted that "the answer is yes." The elimination of OTA is recommended in both the House and Senate budget proposals.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth